Specialty Pharmacy

Two medicines prescribed for the treatment of specific kinds of cancer and an autoinflammatory cardiovascular disease are now available through AllianceRx Walgreens Prime.

Walgreens Boots Alliance hopes to use the investment in the specialty pharmacy company as a means of speeding up the development of new healthcare models and creating a platform from which to build partnerships with health systems.

Hikma will be responsible for commercializing Bilastine once it is FDA approved.

Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions have 21 locations in the United States and Puerto Rico that are licensed to administer Regeneron’s monoclonal antibody treatment.

Amber Specialty Pharmacy will support oncology and bone marrow transplant providers and patients throughout the country.

ParaPro's Natroba is the first product for scabies to be approved by the Food and Drug Administration in more than 30 years.

Optum Frontier Therapies' flagship location will serve rare disease patients in all 50 states. 

Sun Pharma will have the exclusive right to commercialize Winlevi in the United States and Canada, and Cassiopea will be the exclusive supplier of the product.